Sign Up Now
Get instant access to over 1 million+ study documents
OR
Already registered? click here to login
By creating your account, you agree to our terms of service, privacy policy and student honor code.
¶ … regulatory requirements involved will be covered. The report will also include an answer to the question of what three of the file documentation requirements are before a study can be begin at a given site. While the rules and regulations regarding clinical trials may seem arduous and aggravating, they exist for a very good reason.
As explained by the class PowerPoint, the role of the Investigator's Brochure is to offer a compilation of all clinical and non-clinical information that is relevant to a study. It also serves as a reminder and review of the protocol that must be followed. That protocol includes the rationale for the study as well as the compliance that must be part of the study. For the sponsor in particular, the Investigator's Brochure serves several specific needs. These needs include all information known an investigational drug, whether serious or adverse events are "expected" or "unexpected" during the trial, a summary of the reporting requirements that will kick in if/when an adverse event happens and a brochure that provides a framework for the USPI package insert for the drug in question (Investigator's Brochure, 2015).
Basic content that is included in the brochure would include...
name, compound number, etc.) as well as the version number and date. If the version is not the first iteration of a drug being tested, the prior versions should be listed and summarized. A table of contents should give a rough overview of the structure of the document. The first three sections should generally be a quick summary, a list of terms and their definitions and an overall introduction to the study and what is being sought after when it comes to the drug being tested. Up next would generally be the properties of the drug (including physical, chemical and pharmaceutical properties or formulations) and any non-clinical study results that are useful including non-clinical pharmacology, pharmacokinetics and toxicology. Examples of the latter would include its propensity to cause cancer, harm to pregnant mothers and its tendency to mutate. Of course, the effects and safety factors regarding humans would be covered. There would also be a summary of the data and guidance for the investigator as well as a listing of any relevant tables and figures that are relevant to the drug being tested. Three additional documentation requirements that must be mandated or completed…
References
Investigator's Brochure. (2015). Investigator's Brochure. Presentation, Online.
PPD. (2015). Role of Institutional Review Board (IRB)/Ethics Committee in Clinical Trials -- PPD. Ppdi.com. Retrieved 19 September 2015, from http://www.ppdi.com/Participate-In-Clinical-Trials/Become-an-Investigator/Institutional-Review-Board
Since modern medicine can sustain patients with proper medical follow-up for years, it becomes incumbent on the profession to follow the patients and provide them with the knowledge and tracking to insure that they are observing the procedures and medications which prolong their quality of life. Given hospitals' short-term orientation with the patients, there is a need to bridge patient care before, during and after acute-care visits. While there are some
Clinical Decision Support and Electronic Health Records Introduction Information technology has revolutionized nearly every aspect of life, from how people recreate to how they work. This is no less true in the field of health care, where clinical informatics is reshaping the nursing workplace environment, how patient data is recorded and shared, and how health care is delivered. This paper will discuss clinical informatics concepts emerging in the 21st century, what evidence-based
Pharmaceutical industries have to operate in an environment that is highly competitive and subject to a wide variety of internal and external constraints. In recent times, there has been an increasing trend to reduce the cost of operation while competing with other companies that manufacture products that treat similar afflictions and ailments. The complexities in drug research and development and regulations have created an industry that is subject to intense
Nursing (a) provides an account of your observations on the management of peripheral intravascular devices from your clinical practicum in NMIH202; Clinical practicum NM1H202 introduces nurses to the management of peripheral devices via scholarly inquiry and clinical practice. The practicum includes a thorough training in handling, inserting, replacing, and dressing peripheral intravascular devices including peripheral venous catheters. Because the primary risk associated with peripheral intravascular devices is infection, proper management of the
This process does not just help to gain complete understanding of the tasks in hand but also to regularly serve as a reminder of all the legal processes which guide appropriate nursing documentation. The documentation characteristics which are spread all over the nursing field properly addresses the need to efficiently communicate through written methods. One of the main property of proper documentation is that the ability of a nurse to
Computers Used by Nurses The area of interest in nursing informatics are nursing information, nursing data and nursing knowledge. The present state of knowledge related to these phenomena proposes four implications for the development of systems to assist nursing. First, research suggests that experience and knowledge is linked to the quality of nursing assessment, diagnosis or clinical inference, and planning of nursing care, and also that knowledge is task-specific Information technology